Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow

Laboratory Investigation

Volumn 92, Issue 9, 2012, Pages 1330-1341

  Flores Figueroa, Eugenia ^a   Varma, Sushama ^b   Montgomery, Kelli ^b   Greenberg, Peter L ^b   Gratzinger, Dita ^b,c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b STANFORD CANCER INSTITUTE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

bone marrow; CD271; CXCL12; mesenchymal stromal cell; microenvironment; myelodysplastic syndrome

Indexed keywords

CD146 ANTIGEN; NESTIN; PARAFFIN; STROMAL CELL DERIVED FACTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTERIOLE; ARTERY ENDOTHELIUM; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CAPILLARY ENDOTHELIUM; CD34 SELECTION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KRUSKAL WALLIS TEST; LYMPHOMA; MACROPHAGE; MESENCHYMAL STROMA CELL; PARENCHYMA; PERICYTE; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL; TISSUE MICROARRAY; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANTIGENS, CD34; CHEMOKINE CXCL12; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; MYELODYSPLASTIC SYNDROMES; NERVE TISSUE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR;

EID: 84865635864     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.93     Document Type: Article

References (53)

1. Nagasawa T, Omatsu Y, Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol 2011;32:315-320.
2. + cells. Exp Cell Res 2012;318:196-206.
3. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:2079-2088. (Pubitemid 27132124)
4. Swerdlow S. International Agency for Research on Cancer: World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer: Lyon, France, 2008.
5. Muguruma Y, Yahata T, Miyatake H, et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 2006;107:1878-1887. (Pubitemid 43289366)
6. Gottschling S, Saffrich R, Seckinger A, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism. Stem Cells 2007;25:798-806. (Pubitemid 46354240)
7. Van Overstraeten-Schlögel N, Beguin Y, Gothot A. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol 2006;76:488-493.
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
9. Bianco P. Bone and the hematopoietic niche: a tale of two stem cells. Blood 2011;117:5281-5288.
10. Greenberg PL. Current therapeutic approaches for patients with myelodysplastic syndromes. Br J Haematol 2010;150:131-143.
11. Tauro S, Hepburn MD, Bowen DT, et al. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica 2001;86:1038-1045. (Pubitemid 33031869)
12. Flores-Figueroa E, Gutierrez-Espindola G, Montesinos JJ, et al. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 2002;26:677-686. (Pubitemid 34465704)
13. Kitagawa M, Saito I, Kuwata T, et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997;11:2049-2054. (Pubitemid 28043688)
14. Ohmori S, Ohmori M, Yamagishi M, et al. MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones. Br J Haematol 1993;83:388-391. (Pubitemid 23080007)
15. Flores-Figueroa E, Arana-Trejo RM, Gutierrez-Espindola G, et al. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005;29:215-224. (Pubitemid 39647516)
16. Blau O, Hofmann WK, Baldus CD, et al. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. Exp Hematol 2007;35:221-229. (Pubitemid 46135819)
17. Lopez-Villar O, Garcia JL, Sanchez-Guijo FM, et al. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome. Leukemia 2009;23:664-672.
18. Blau O, Baldus CD, Hofmann W-K, et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood 2011;118:5583-5592.
19. Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010;464:852-857.
20. Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30:783-791. (Pubitemid 34835685)
21. Conrad C, Zeindl-Eberhart E, Moosmann S, et al. Alkaline phosphatase, glutathione-S-transferase-P, and cofilin-1 distinguish multipotent mesenchymal stromal cell lines derived from the bone marrow versus peripheral blood. Stem Cells Dev 2008;17:23-27. (Pubitemid 351271618)
22. Westen H, Bainton DF. Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors. J Exp Med 1979;150:919-937. (Pubitemid 10227339)
23. Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
24. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131:324-336. (Pubitemid 47592917)
25. Omatsu Y, Sugiyama T, Kohara H, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010;33:387-399.
26. Cattoretti G, Schiro R, Orazi A, et al. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-1738. (Pubitemid 23101584)
27. Sharma M, Afrin F, Satija N, et al. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 2011;20:933-946.
28. Matsuda M, Morita Y, Hanamoto H, et al. CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma. Leukemia 2004;18:1038-1040. (Pubitemid 38714636)
29. Yang R, Pu J, Guo J, et al. The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome. Med Oncol 2011.
30. Brown DC, Gatter KC. The bone marrow trephine biopsy: a review of normal histology. Histopathology 1993;22:411-422. (Pubitemid 23168581)
31. Weiss L. The structure of bone marrow. Functional interrelationships of vascular and hematopoietic compartments in experimental hemolytic anemia: an electron microscopic study. J Morphol 1965;117:467-537.
32. Burkhardt R, Kettner G, Böhm W, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987;8:157-164. (Pubitemid 17111858)
33. Thiele J, Rompcik V, Wagner S, et al. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow. Br J Haematol 1992;80:227-234.
34. Baschong W, Suetterlin R, Laeng RH. Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J Histochem Cytochem 2001;49:1565-1572.
35. Collins TJ. ImageJ for microscopy. BioTechniques 2007;43(1 Suppl):25-30.
36. Christiansen P, Steiniche T, Vesterby A, et al. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992;13:41-49.
37. Caneva L, Soligo D, Cattoretti G, et al. Immuno-electron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 1995;21:73-85.
38. Tormin A, Li O, Brune JC, et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011;117:5067-5077.
39. Maijenburg MW, Kleijer M, Vermeul K, et al. The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging. Haematologica 2011;97:179-183.
40. Sugawara K, Kurihara H, Negishi M, et al. Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 2002;82:345-351. (Pubitemid 34242527)
41. Aihara M, Sugawara K, Torii S, et al. Angiogenic endothelium-specific nestin expression is enhanced by the first intron of the nestin gene. Lab Invest 2004;84:1581-1592. (Pubitemid 39600565)
42. Ferraro F, Lymperi S, Méndez-Ferrer S, et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011;3(104):104ra101.
43. Corselli M, Chen C-W, Crisan M, et al. Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 2010;30:1104-1109.
44. Battula VL, Treml S, Bareiss PM, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009;94:173-184.
45. Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006;25:977-988. (Pubitemid 44894948)
46. Askmyr M, Sims NA, Martin TJ, et al. What is the true nature of the osteoblastic hematopoietic stem cell niche? Trends Endocrinol Metab 2009;20:303-309.
47. Churchman SM, Ponchel F, Boxall SA, et al. Native CD271(+) multipotential stromal cells (MSCs) have a transcript profile indicative of multiple fates with prominent osteogenic and Wnt pathway signalling activity. Arthritis Rheum 2012, Available at http://www.ncbi.nlm.nih.gov/pubmed/22378497.
48. Lataillade JJ, Clay D, Dupuy C, et al. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000;95:756-768. (Pubitemid 30062693)
49. Lataillade J-J, Clay D, Bourin P, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002;99:1117-1129. (Pubitemid 34547062)
50. Chabanon A, Desterke C, Rodenburger E, et al. A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin. Stem Cells 2008;26:3150-3161.
51. Fuhler GM, Drayer AL, Olthof SGM, et al. Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia. Blood 2008;111:359-368.
52. Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 2009;114: 1150-1157.
53. Verburgh E, Achten R, Maes B, et al. Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes. J Clin Oncol 2003;21:273-282. (Pubitemid 46606156)